A Phase 3 Biomarker Validation of GALAD for the Detection of Hepatocellular Carcinoma in Cirrhosis is a research paper published in Gastroenterology (2024). On theSindex it has a DataRank of 0. It has been cited 73 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute Division of Cancer Prevention
Grant: R01 CA237659
National Cancer Institute
Grant: R01 CA222900
National Cancer Institute
Grant: U01 CA086402
National Cancer Institute
Grant: U24 CA086368
National Cancer Institute
Grant: U01 CA230694
NCI NIH HHS
Grant: U01 CA271887
National Institutes of Health
FWCI
18.65
Citation Percentile
1.0%
Influential Citations
8
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals